Novo A/S increases its shareholding in Orexo AB

Hellerup, August 26 - 2010

Novo A/S announced it has increased its ownership position in Orexo AB (STO: ORX) by acquiring an additional 1,397,142 shares representing approximately 6.0% of the current outstanding shares of the company. Upon the closing of the transaction, Novo A/S will own 3,893,184 shares, or approximately 16.7% of the Swedish specialty pharmaceuticals company. Furthermore, Novo A/S holds an Orexo convertible bond, which if converted would represent an additional 2,340,000 shares equal to approximately 8.1% of the company after conversion, giving Novo A/S a 24.2% share of the total ownership on an as-converted basis.

Click here to read the press release.